Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Drug Discovery Today|December 3, 2004
The use of cell-penetrating peptides for drug deliveryJamal Temsamani, Pierre VidalBiochimica Et Biophysica Acta|February 21, 2002
Translocation of protegrin I through phospholipid membranes: role of peptide foldingGuillaume Drin, Jamal TemsamaniJournal of Neurochemistry|September 3, 2003
Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrierFanchon Bourasset, Salvatore Cisternino, Jamal Temsamani, et al.Journal of Drug Targeting|August 8, 2002
Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategyChristophe Rousselle, Philippe Clair, Jamal Temsamani, et al.Psychopharmacology|October 29, 2010
The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptorsJulie Espallergues, Jamal Temsamani, Claude Laruelle, et al.Psychoneuroendocrinology|January 2, 2009
The 3beta-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in miceJulie Espallergues, Laurent Givalois, Jamal Temsamani, et al.The Journal of Biological Chemistry|June 5, 2003
Studies on the internalization mechanism of cationic cell-penetrating peptidesGuillaume Drin, Sylvine Cottin, Emmanuelle Blanc, et al.AAPS Pharmsci|March 21, 2003
Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectorsGuillaume Drin, Christophe Rousselle, Jean-Michel Scherrmann, et al.Anti-Cancer Drugs|June 19, 2004
2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistanceCédric Castex, Peggy Merida, Emmanuelle Blanc, et al.Anti-Cancer Drugs|October 30, 2004
Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxelEmmanuelle Blanc, Cécile Bonnafous, Peggy Merida, et al.Pageof 2